INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Drug discovery is a complex process carried out by pharmacists carefully that can take up to years. Data in healthcare has become increasingly digitalized over time, particularly in the pharmaceutical industry. However, this presents numerous difficulties, such as acquiring, examining, and applying that knowledge to resolve clinical issues that can be excessively complex. Introduction of Artificial Intelligence has been proven to reduce the human workloads in this sector. Artificial intelligence refers to the processing of human intellect by machines, particularly computer systems. Medical chemistry has been applying AI in drug development since 1960s. Quantitative Structure-Activity Relationship (QSAR) approach is a prime example of this. QSAR is frequently used to forecast properties of chemical structures, including bioactivity and solubility, among others.
Keywords:
Artificial intelligence, Drug development, Drug designing, pharmaceutical, Drug
Cite Article:
"AI IN DRUG DEVELOPMENT", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 3, page no.1207 - 1210, March-2023, Available :http://www.ijsdr.org/papers/IJSDR2303197.pdf
Downloads:
000336256
Publication Details:
Published Paper ID: IJSDR2303197
Registration ID:204733
Published In: Volume 8 Issue 3, March-2023
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.33881
Page No: 1207 - 1210
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn